Pharmaceuticals 2010, 3(2), 323-344; doi:10.3390/ph3020323
Review

Oromucosal Administration of Interferon to Humans

Manfred W. Beilharz 1,* email, Martin J. Cummins 2 email, Alayne L. Bennett 1 email and Joseph M. Cummins 2 email
1 School of Biomedical, Biomolecular and Chemical Sciences, University of Western Australia, 35 Stirling Highway, Crawley WA 6009, Australia 2 Amarillo Biosciences, Inc., 4134 Business Park Drive, Amarillo, TX 79110, USA
* Author to whom correspondence should be addressed.
Received: 1 December 2009; in revised form: 20 January 2010 / Accepted: 25 January 2010 / Published: 28 January 2010
(This article belongs to the Special Issue Interferons)
PDF Full-text Download PDF Full-Text [337 KB, uploaded 28 January 2010 10:39 CET]
Abstract: The prevailing dogma is that, to be systemically effective, interferon-alpha (IFNα) must be administered in sufficiently high doses to yield functional blood concentrations. Such an approach to IFNa therapy has proven effective in some instances, but high-dose parenteral IFNα therapy has the disadvantage of causing significant adverse events. Mounting evidence suggests that IFNα delivered into the oral cavity in low doses interacts with the oral mucosa in a unique manner to induce systemic host defense mechanisms without IFNα actually entering the circulation, thus reducing the potential for toxic side effects. A better understanding of the applications and potential benefits of this treatment modality are under active investigation. This paper provides a review of the relevant literature on the clinical use of the oromucosal route of administration of interferon, with an emphasis on the treatment of influenza.
Keywords: interferon; oromucosal delivery; influenza; treatment; viral diseases

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Beilharz, M.W.; Cummins, M.J.; Bennett, A.L.; Cummins, J.M. Oromucosal Administration of Interferon to Humans. Pharmaceuticals 2010, 3, 323-344.

AMA Style

Beilharz MW, Cummins MJ, Bennett AL, Cummins JM. Oromucosal Administration of Interferon to Humans. Pharmaceuticals. 2010; 3(2):323-344.

Chicago/Turabian Style

Beilharz, Manfred W.; Cummins, Martin J.; Bennett, Alayne L.; Cummins, Joseph M. 2010. "Oromucosal Administration of Interferon to Humans." Pharmaceuticals 3, no. 2: 323-344.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert